Rock Springs Capital Management »

Glaukos shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of Glaukos (GKOS) shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in Glaukos

Tip: Access up to 7 years of quarterly data

All positions including Glaukos held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glaukos by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $664k 4.8k 139.76
2017-06-30 $2.6M 63k 41.47
2017-03-31 $3.2M 63k 51.30

More positions owned by Rock Springs Capital Management

Revolution Medicines (RVMD)
Travere Therapeutics (TVTX)
Eli Lilly & Co. (LLY)
Madrigal Pharmaceuticals (MDGL)
Mirum Pharmaceuticals (MIRM)
Rhythm Pharmaceuticals (RYTM)
Kymera Therapeutics (KYMR)
Argenx Se Sponsored Adr (ARGX)
Ascendis Pharma A/s Ord Shs (ASND)
Xenon Pharmaceuticals (XENE)
Scholar Rock Hldg Corp (SRRK)
Insmed Com Par $.01 (INSM)
Penumbra (PEN)
Structure Therapeutics Sponsored Ads (GPCR)
Ultragenyx Pharmaceutical (RARE)

View all positions for Rock Springs Capital Management

Top funds holding Glaukos

BlackRock
Henderson Group
Jupiter Topco
Vanguard Portfolio Management
PRIMECAP Management Company
Vanguard Capital Management
State Street Corporation
Millennium Management
Holocene Advisors
Geode Capital Management
Citadel Advisors
Ameriprise Financial
Alliancebernstein
Capital World Investors
Goldman Sachs Group

View all funds holding Glaukos